Tenet Beats Q2 Earnings on Strong Patient Volumes, Hikes '25 EPS View

  • THC's Q2 earnings benefit on the back of strong volumes, facility buyouts, higher acuity and favorable payer mix. It currently expects 2025 adjusted EPS within $15.55-$16.21, up from the earlier view of $11.99-$13.12.